To give accurate information is our responsibility
A robust CAGR and growing demand for targeted therapies set the stage for the transformative growth of bispecific antibody contract development and manufacturing across global …
The global neoantigen cancer vaccine market was valued at USD 475.68 million in 2025 and is forecasted to escalate impressively to approximately USD 1,799.21 million …
The global checkpoint inhibitor biologics CDMO market is projected to see remarkable growth from 2025 to 2034, driven by rising oncology pipelines, technological advances, and …
The global RNA interference (RNAi) drug delivery market, valued at USD 118.18 billion in 2025, is on a remarkable growth trajectory expected to reach approximately …
The global exosome-based cancer therapy contract development and manufacturing organization (CDMO) market is witnessing rapid growth, propelled by advancements in exosome technology, rising cancer prevalence, …
The global cell encapsulation technology market is projected to grow significantly, driven by advances in biocompatible materials, immunoprotective systems, and AI-enabled research. Valued strongly today, …
Precision Therapies, AI-Driven Innovations, and Tumor-Targeting Viruses Ignite Growth in Cancer Gene Therapy The global oncolytic virus-based gene therapy market is entering a high-growth era, …
The global in vivo cell reprogramming market is poised for substantial expansion, projected to witness strong growth with a CAGR reflecting increasing clinical applications in …
The global in-situ hybridization market size was valued at USD 1,870 million in 2025 and is projected to reach USD 3,600 million by 2034, growing …
Revolutionizing cancer treatment with targeted immunotherapy, the engineered TCR therapy market is forecast to grow rapidly at a robust CAGR driven by technological innovations and …
by